drugset / Trial / NCT00458146
A Phase 2 Study to Evaluate the Efficacy and Safety of 60mg of MM-093 in Patients With Active Rheumatoid Arthritis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether MM-093 is safe and effective in the treatment of RA.
Timeline
- Start
- 2007-02
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MM-093 | Protein / enzyme biologic | 60 mg | Subcutaneous |